These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 3498863)

  • 21. Therapeutic progress: trimethoprim-sulfamethoxazole.
    Ruiz López R; Saavedra S; Ramírez-Ronda CH
    Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635
    [No Abstract]   [Full Text] [Related]  

  • 22. Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy.
    Blaser J; Joos B; Opravil M; Lüthy R
    Infection; 1993; 21(4):206-9. PubMed ID: 8225622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
    Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
    Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia.
    Dorr RT; Powell JR; Heick M; Barry DW
    Postgrad Med J; 1981 Feb; 57(664):123-5. PubMed ID: 6973756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.
    Young LS; Hindler J
    Rev Infect Dis; 1987; 9 Suppl 2():S177-83. PubMed ID: 3554456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections.
    Quintiliani R; Levitz RE; Nightingale CH
    Rev Infect Dis; 1987; 9 Suppl 2():S160-7. PubMed ID: 3554454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia.
    Mitsuyasu RT; Corwin HL; Harris AA; Trenholme GM; Levi S; Karkusis PH
    Am Rev Respir Dis; 1982 Jun; 125(6):762-5. PubMed ID: 6979960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection.
    Nicolle LE; Harding GK; Thomson M; Kennedy J; Urias B; Ronald AR
    J Infect Dis; 1988 Jun; 157(6):1239-42. PubMed ID: 3259613
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mycetomas with pulmonary dissemination].
    Welsh Lozano O; López López JR
    Med Cutan Ibero Lat Am; 1985; 13(6):517-23. PubMed ID: 3914605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation.
    Higgins RM; Bloom SL; Hopkin JM; Morris PJ
    Transplantation; 1989 Mar; 47(3):558-60. PubMed ID: 2646786
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of Sulfamethoxazole and Trimethoprim During Venovenous Extracorporeal Membrane Oxygenation: A Case Report.
    Dhanani JA; Lipman J; Pincus J; Townsend S; Livermore A; Wallis SC; Pandey S; Abdul-Aziz MH; Roberts JA
    Pharmacotherapy; 2020 Jul; 40(7):713-717. PubMed ID: 32378219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consideration of the uses and risks of co-trimoxazole from the therapeutic point of view.
    Lode H
    Infection; 1987; 15 Suppl 5():S231. PubMed ID: 3501771
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of Nocardia asteroides infection with trimethoprim-sulfamethoxazole.
    Cook FV; Farrar WE
    South Med J; 1978 May; 71(5):512-5. PubMed ID: 347585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfamethoxazole-trimethoprim treatment of guinea pigs infected with Legionella pneumophila.
    Plouffe JF; Para MF; Bollin GE
    J Infect Dis; 1984 Nov; 150(5):780-2. PubMed ID: 6333470
    [No Abstract]   [Full Text] [Related]  

  • 39. Single-dose trimethoprim-sulfamethoxazole prophylaxis for cesarean section.
    Ganesh V; Apuzzio JJ; Dispenziere B; Patel K; Bergen B; Louria DB
    Am J Obstet Gynecol; 1986 May; 154(5):1113-4. PubMed ID: 3486596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute urinary tract infection with three doses of co-trimoxazole.
    Rapoport J; Rees GA; Willmott NJ; Slack RC; O'Grady FW
    Br Med J (Clin Res Ed); 1981 Nov; 283(6302):1302-3. PubMed ID: 6794832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.